RxDoctor Payments Data

Atoosa Kashani, DPM

Podiatrist · Annandale, VANPI 1437271889

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations.

$2,450in general payments, 2019–2025

Across 48 payments — averaging $51.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cardiovascular Systems Inc.$343
  • Smith+Nephew$254
  • Stryker$230
  • Biocomposites Inc$221
  • Nevro Corp.$176
  • Convatec Inc.$164
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$2,450100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,450 in reported general payments places this provider in the 65th percentile of 126 podiatrist providers in Virginia.

See all podiatrist providers in Virginia

Medicare billing

Part B allowed, 2024
$147,751
Medicare patients
534
Services billed
1,475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Imiquimod14$705
Ciclopirox31$674
Ammonium Lactate40$547
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip23$326
Gabapentin37$251
Ketoconazole11$239
Silver Sulfadiazine24$188
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$183
Doxycycline Hyclate19$121
Meloxicam11$13

Paid to pharmacies, not to this prescriber.

Other podiatrist in Annandale

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →